Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12595314 | Antibody specific for GPC3 and methods of use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-07-31 | 0 | 31 |
| 12595298 | Anti-NGF antibody and antigen-binding fragment thereof, preparation method, and application thereof | 🖼🧊📄§ | 2026-04-07 | 2041-08-02 | 0 | 31 |
| 12595292 | Interleukin-2 receptor (IL2R) and interleukin-2 (IL2) variants for specific activation of immune effector cells | 🖼🧊📄§ | 2026-04-07 | 2040-03-16 | 0 | 31 |
| 12595290 | T cell receptors specific for mesothelin and their use in immunotherapy | 🖼🧊📄§ | 2026-04-07 | 2039-11-08 | 0 | 31 |
| 12595303 | Antibodies and chimeric antigen receptors that target TACI | 🖼🧊📄§ | 2026-04-07 | 2040-06-04 | 0 | 31 |
| 12595470 | Engineered nucleases that target human and canine factor VIII genes as a treatment for hemophilia A | 🖼🧊📄§ | 2026-04-07 | 2044-02-23 | 0 | 31 |
| 12595486 | Aptamers for personal health care applications | 🖼🧊📄§ | 2026-04-07 | 2042-12-14 | 0 | 31 |
| 12595310 | Compositions and methods for transferrin receptor 1 targeting | 🖼🧊📄§ | 2026-04-07 | 2040-11-06 | 0 | 31 |
| 12595278 | Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway | 🖼🧊📄§ | 2026-04-07 | 2043-10-12 | 0 | 31 |
| 12594261 | Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases | 🖼🧊📄§ | 2026-04-07 | 2039-12-14 | 0 | 31 |
| 12594256 | A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy | 🖼🧊📄§ | 2026-04-07 | 2043-05-18 | 0 | 31 |
| 12594249 | Soluble curcumin and its derivatives | 🖼🧊📄§ | 2026-04-07 | 2044-06-03 | 0 | 31 |
| 12594244 | Therapeutic compositions for treatment of human immunodeficiency virus | 🖼🧊📄§ | 2026-04-07 | 2045-09-29 | 0 | 31 |
| 12594276 | Inhibitors of human immunodeficiency virus replication | 🖼🧊📄§ | 2026-04-07 | 2045-02-03 | 0 | 31 |
| 12594283 | Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug | 🖼🧊📄§ | 2026-04-07 | 2040-10-26 | 0 | 31 |
| 12594324 | Methods and compositions for treatment of pancreatic cancer | 🖼🧊📄§ | 2026-04-07 | 2040-06-30 | 0 | 31 |
| 12594288 | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection | 🖼🧊📄§ | 2026-04-07 | 2043-06-05 | 0 | 31 |
| 12595483 | Treatment of tumors with miRNA targeting CDK4/CDK6 | 🖼🧊📄§ | 2026-04-07 | 2043-11-16 | 0 | 31 |
| 12594278 | Method for treatment of muscular dystrophy | 🖼🧊📄§ | 2026-04-07 | 2040-07-16 | 0 | 31 |
| 12595280 | Phosphoramidates for the treatment of hepatitis B virus | 🖼🧊📄§ | 2026-04-07 | 2044-04-11 | 0 | 31 |
| 12595285 | LMP-1 expressing cells and methods of use thereof | 🖼🧊📄§ | 2026-04-07 | 2042-05-13 | 0 | 31 |
| 12595250 | Substituted pyrimidine compounds as multifunctional radical quenchers and their uses | 🖼🧊📄§ | 2026-04-07 | 2042-06-15 | 0 | 31 |
| 12595300 | Anti-human P40 protein domain antibody and use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-07-28 | 0 | 31 |
| 12595293 | Anti-follicle stimulating hormone receptor antibodies | 🖼🧊📄§ | 2026-04-07 | 2039-08-09 | 0 | 31 |
| 12595232 | DRG-MDM2-1 for use as a novel Mouse Double Minute 2 (MDM2) inhibitor | 🖼🧊📄§ | 2026-04-07 | 2041-02-16 | 0 | 31 |
| 12595302 | CLDN18.2 binding molecule | 🖼🧊📄§ | 2026-04-07 | 2040-05-21 | 0 | 31 |
| 12595517 | Method to treat and stratify a patient suffering from a cancer | 🖼🧊📄§ | 2026-04-07 | 2041-09-13 | 0 | 31 |
| 12594308 | Methods of preparing a postbiotic composition | 🖼🧊📄§ | 2026-04-07 | 2044-10-08 | 0 | 31 |
| 12595259 | Aminopyridine compound | 🖼🧊📄§ | 2026-04-07 | 2041-06-17 | 0 | 31 |
| 12595289 | Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2 | 🖼🧊📄§ | 2026-04-07 | 2039-11-28 | 0 | 31 |
| 12595306 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2044-12-23 | 0 | 31 |
| 12595305 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2042-09-23 | 0 | 31 |
| 12595304 | Antibodies specific to glycosylated LAG3 and methods of use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-10-09 | 0 | 31 |
| 12595309 | Compositions and methods for treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-07 | 2044-11-08 | 0 | 31 |
| 12595312 | CD133-binding agents and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-10-26 | 0 | 31 |
| 12593863 | Probiotics to prevent cognitive dysfunction | 🖼🧊📄§ | 2026-04-07 | 2041-10-08 | 0 | 31 |
| 12589136 | Viral vectors comprising RDH12 coding regions and methods of treating retinal dystrophies | 🖼🧊📄§ | 2026-03-31 | 2042-08-09 | 0 | 31 |
| 12590304 | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | 🖼🧊📄§ | 2026-03-31 | 2040-05-21 | 0 | 31 |
| 12590335 | Targeted measure of transcriptional activity related to hormone receptors | 🖼🧊📄§ | 2026-03-31 | 2043-06-21 | 0 | 31 |
| 12590309 | Reprogramming of lipid metabolism to inhibit T cell senescence and enhance tumor immunotherapy | 🖼🧊📄§ | 2026-03-31 | 2040-05-19 | 0 | 31 |
| 12589125 | Yogurt for regulating intestinal tract, preparation method therefor, and use thereof | 🖼🧊📄§ | 2026-03-31 | 2043-02-27 | 0 | 31 |
| 12590168 | Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof | 🖼🧊📄§ | 2026-03-31 | 2044-01-23 | 0 | 31 |
| 12590123 | Compounds and methods for treating cancer, viral infections, and allergic conditions | 🖼🧊📄§ | 2026-03-31 | 2040-06-25 | 0 | 31 |
| 12590139 | MHC class II molecules and methods of use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-07-29 | 0 | 31 |
| 12590103 | Polymorph of EP4 receptor antagonist, preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-31 | 2041-01-29 | 0 | 31 |
| 12590157 | Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments | 🖼🧊📄§ | 2026-03-31 | 2043-07-20 | 0 | 31 |
| 12589133 | Methods of downregulating CCL20 genes for treatment of traumatic brain injuries | 🖼🧊📄§ | 2026-03-31 | 2041-11-10 | 0 | 31 |
| 12590100 | Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-β-TrCP interaction for use in the treatment of fatty liver disease | 🖼🧊📄§ | 2026-03-31 | 2042-01-13 | 0 | 31 |
| 12590149 | Antibody and bispecific antibody targeting LAG-3 and use thereof | 🖼🧊📄§ | 2026-03-31 | 2040-06-11 | 0 | 31 |
| 12589122 | Methods and compositions for treating infectious, autoimmune, and allergic disease | 🖼🧊📄§ | 2026-03-31 | 2039-11-05 | 0 | 31 |